The FASEB Journal, Vol 7, 931-937, Copyright © 1993 by The Federation of American Societies for Experimental Biology

RESEARCH COMMUNICATIONS

RB1 protein in normal and malignant human colorectal tissue and colon cancer cell lines

AA Ali, JN Marcus, JP Harvey, R Roll, CP Hodgson, DM Wildrick, A Chakraborty and BM Boman
Creighton Cancer Center, Creighton University School of Medicine, Omaha, Nebraska 68178.

The pattern of human retinoblastoma (RB1) gene protein expression was directly examined in normal and malignant human colorectal tissues and in seven colorectal carcinoma cell lines by immunohistochemistry using the mouse monoclonal antibody (RB-MAb-1) directed against the retinoblastoma protein (RB). This is the first demonstration of RB immunostaining in adult human colonic epithelium and colorectal carcinomas. Specificity using RB-MAb-1 was confirmed by western blot analysis, which showed bands of 110-116 kDa corresponding to the sizes of unphosphorylated and phosphorylated RB. RB staining of normal adult colonic epithelium was confined to the nucleus and was most intense in the transitional zone of the crypt, whereas lumenal cells (fully differentiated) were RB negative. Primary colorectal carcinomas and all the colon cancer cell lines stained positively for nuclear RB, but the expression was heterogeneous with varying fractions of RB negative cells present. Because we and others have previously shown that loss or inactivation of the RB1 gene is infrequent in colorectal carcinomas, reduced RB expression in such cells is probably due to a cellular regulatory mechanism. For example, RB negative cells may be those in early-G1 phase (known to have reduced RB levels) or growth-arrested cells that have differentiated. The ability to directly detect RB in primary colorectal carcinomas will permit assessment of whether heterogeneous expression of the RB1 gene product has prognostic significance for survival of patients with this cancer.

This article has been cited by other articles:

				S. Volinia, G. A. Calin, C.-G. Liu, S. Ambs, A. Cimmino, F. Petrocca, R. Visone, M. Iorio, C. Roldo, M. Ferracin, et al. A microRNA expression signature of human solid tumors defines cancer gene targets PNAS, February 14, 2006; 103(7): 2257 - 2261. [Abstract] [Full Text] [PDF]

				K. Haigis, J. Sage, J. Glickman, S. Shafer, and T. Jacks The Related Retinoblastoma (pRb) and p130 Proteins Cooperate to Regulate Homeostasis in the Intestinal Epithelium J. Biol. Chem., January 6, 2006; 281(1): 638 - 647. [Abstract] [Full Text] [PDF]

				I. Hostein, D. Robertson, F. DiStefano, P. Workman, and P. Andrew Clarke Inhibition of Signal Transduction by the Hsp90 Inhibitor 17-Allylamino-17-demethoxygeldanamycin Results in Cytostasis and Apoptosis Cancer Res., May 1, 2001; 61(10): 4003 - 4009. [Abstract] [Full Text]

				J. A. McKay, J. J. Douglas, V. G. Ross, S. Curran, F. Y. Ahmed, J. F. Loane, G. I. Murray, and H. L. McLeod Expression of Cell Cycle Control Proteins in Primary Colorectal Tumors Does Not Always Predict Expression in Lymph Node Metastases Clin. Cancer Res., March 1, 2000; 6(3): 1113 - 1118. [Abstract] [Full Text]

				H. Yamamoto, J.-W. Soh, T. Monden, M. G. Klein, L. M. Zhang, H. Shirin, N. Arber, N. Tomita, I. Schieren, C. A. Stein, et al. Paradoxical Increase in Retinoblastoma Protein in Colorectal Carcinomas May Protect Cells from Apoptosis Clin. Cancer Res., July 1, 1999; 5(7): 1805 - 1815. [Abstract] [Full Text] [PDF]

				J. Mitra, C. Y. Dai, K. Somasundaram, W. S. El-Deiry, K. Satyamoorthy, M. Herlyn, and G. H. Enders Induction of p21WAF1/CIP1 and Inhibition of Cdk2 Mediated by the Tumor Suppressor p16INK4a Mol. Cell. Biol., May 1, 1999; 19(5): 3916 - 3928. [Abstract] [Full Text] [PDF]